Page last updated: 2024-08-23

androstane-3,17-diol and Hyperlipemia

androstane-3,17-diol has been researched along with Hyperlipemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Diamanti-Kandarakis, E; Duleba, AJ; Mitrakou, A; Raptis, S; Tolis, G	1

Other Studies

1 other study(ies) available for androstane-3,17-diol and Hyperlipemia

Article	Year
The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome. The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:8 Topics: Adult; Androgen Antagonists; Androstane-3,17-diol; Androstenedione; Cholesterol; Dehydroepiandrosterone Sulfate; Female; Flutamide; Humans; Hyperlipidemias; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Liver Function Tests; Obesity; Polycystic Ovary Syndrome; Testosterone; Triglycerides	1998

Article

Year

The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome.

The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:8

Topics: Adult; Androgen Antagonists; Androstane-3,17-diol; Androstenedione; Cholesterol; Dehydroepiandrosterone Sulfate; Female; Flutamide; Humans; Hyperlipidemias; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Liver Function Tests; Obesity; Polycystic Ovary Syndrome; Testosterone; Triglycerides

1998